The company have substantially boosted this progress of an novel therapy for amyloid heart disease, leveraging Attruby. Initial trial results reveals significant improvements for patients affected by a severe condition. https://biotech318013.humor-blog.com/40552397/bridgebio-progresses-cardiac-amyloidosis-treatment-through-the-drug